Kaken Pharmaceutical Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Japan.
P/E ratio
66.8Investors pay 66.8 for every 1 of Kaken Pharmaceutical Co., Ltd.'s yearly profit, higher than 97% of Healthcare companies in Japan.
P/B ratio
0.97The share price is 0.97 times Kaken Pharmaceutical Co., Ltd.'s book value per share, lower than 71% of Healthcare companies in Japan.
Market cap
¥143.5 BThe total market value of all of Kaken Pharmaceutical Co., Ltd.'s shares at today's price (share price × number of shares), larger than 62% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Return on equity (ROE)
6.9%Kaken Pharmaceutical Co., Ltd. earned 6.9% on its shareholders' money over the last year, lower than 67% of Healthcare companies in Japan.
Dividend yield
4.92%Kaken Pharmaceutical Co., Ltd. pays 4.92% of its share price as dividends a year, higher than 97% of dividend-paying Healthcare companies in Japan.
Questions
What is Kaken Pharmaceutical Co., Ltd.'s P/E ratio?
Investors pay 66.8 for every 1 of Kaken Pharmaceutical Co., Ltd.'s yearly profit, higher than 97% of Healthcare companies in Japan.
What is Kaken Pharmaceutical Co., Ltd.'s return on equity?
Kaken Pharmaceutical Co., Ltd. earned 6.9% on its shareholders' money over the last year, lower than 67% of Healthcare companies in Japan.
Does Kaken Pharmaceutical Co., Ltd. pay a dividend?
Yes. Kaken Pharmaceutical Co., Ltd. pays 4.92% of its share price as dividends a year, higher than 97% of dividend-paying Healthcare companies in Japan.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.